European Union Drugs Agency koordiniert europaeische Drogenbeobachtung, Fruehwarnsysteme und evidenzbasierte Informationen zu Konsum, Risiken und Politik

The European Union Drugs Agency coordinates drug monitoring, early warning, and evidence-based information across the EU. Its role centers on tracking drug use patterns, health and social harms, emerging substances, and policy responses that support public health and security decisions. The agency maintains data systems, publishes assessments, and supports national focal points that feed comparable information into a European picture of drug trends. It also contributes to rapid risk communication on new psychoactive substances and other developments that may threaten health. EU-level coordination matters because drug markets, trafficking routes, and novel compounds move across borders faster than isolated national systems can respond. Shared monitoring and analysis help governments, services, and researchers detect change earlier and shape more informed prevention, treatment, and regulatory strategies.